Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 401 entries
View as:

Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)

Phase: N/A Priority: Normal
NCT ID: NCT00996723 Org: User:
Start: 10/31/09 End: 06/30/14 Due: 06/30/15

Pharmacogenetic Determinants Of Treatment Response In Children

Phase: N/A Priority: Normal
NCT ID: NCT00730678 Org: User:
Start: 08/17/98 End: 03/31/34 Due: 03/31/35

Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT00532883 Org: User:
Start: 01/31/07 End: 08/31/09 Due: 08/31/10

Immunologic Features of Respiratory Failure in Pediatric Hematopoietic Cell Transplantation (HCT) Recipients and Pediatric Oncology Patients

Phase: N/A Priority: Normal
NCT ID: NCT04355780 Org: User:
Start: 01/08/21 End: 08/30/23 Due: 08/30/24

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06421987 Org: User:
Start: 05/06/24 End: 03/31/27 Due: 03/31/28

Patient-Reported Outcome Version of the Common Criteria for Adverse Events

Phase: N/A Priority: Normal
NCT ID: NCT04050072 Org: User:
Start: 12/16/19 End: 07/31/26 Due: 07/31/27

A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01440283 Org: User:
Start: 09/30/11 End: 03/31/15 Due: 03/31/16

Social Experiences of Adolescents and Young Adults With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04328350 Org: User:
Start: 10/12/20 End: 12/31/26 Due: 12/31/27

Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT02415816 Org: User:
Start: 06/05/15 End: 04/30/27 Due: 04/30/28

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05664126 Org: User:
Start: 08/01/23 End: 12/31/29 Due: 12/31/30

Vibration Intervention For Bone Enhancement In Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01010230 Org: User:
Start: 05/31/10 End: 03/31/13 Due: 03/31/14

Childhood Cancer Survivor Study

Phase: N/A Priority: Normal
NCT ID: NCT01120353 Org: User:
Start: 01/05/95 End: 11/30/26 Due: 11/30/27

Trial of Antibody Responses by Vitamin Supplementation

Phase: N/A Priority: Normal
NCT ID: NCT03859687 Org: User:
Start: 08/19/19 End: 01/12/27 Due: 01/12/28

Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images

Phase: N/A Priority: Normal
NCT ID: NCT04125095 Org: User:
Start: 01/28/20 End: 10/31/27 Due: 10/31/28

Lactation Outcomes Among Survivors of Pediatric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02399956 Org: User:
Start: 03/31/15 End: 12/31/15 Due: 12/31/16

Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00760227 Org: User:
Start: 01/31/03 End: - Due: -

Evaluating the Clinical Utility of the T-SPOT.CMV Assay for the Prediction of CMV Reactivation Among Pediatric Patients Undergoing Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03570411 Org: User:
Start: 07/16/18 End: 04/22/19 Due: 04/22/20

Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

Phase: N/A Priority: Normal
NCT ID: NCT05810181 Org: User:
Start: 06/01/23 End: 12/31/26 Due: 12/31/27

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Phase: N/A Priority: Normal
NCT ID: NCT00136084 Org: User:
Start: 08/31/02 End: 06/30/12 Due: 06/30/13

iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02564484 Org: User:
Start: 02/08/16 End: 07/09/24 Due: 07/09/25

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

Phase: N/A Priority: Normal
NCT ID: NCT04416178 Org: User:
Start: 12/17/20 End: 03/26/24 Due: 03/26/25

Markers of Anthracycline-Related Cardiac Muscle Injury

Phase: N/A Priority: Normal
NCT ID: NCT01112800 Org: User:
Start: 05/31/10 End: 01/31/13 Due: 01/31/14

Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00718757 Org: User:
Start: 01/31/05 End: 01/31/09 Due: 01/31/10

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06819475 Org: User:
Start: 06/02/25 End: 01/31/28 Due: 01/31/29

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03164057 Org: User:
Start: 06/15/17 End: 06/30/27 Due: 06/30/28